Dr Reddy's Laboratories Ltd banner

Dr Reddy's Laboratories Ltd
NSE:DRREDDY

Watchlist Manager
Dr Reddy's Laboratories Ltd Logo
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Watchlist
Price: 1 311.5 INR 1.9% Market Closed
Market Cap: ₹1.1T

Relative Value

The Relative Value of one DRREDDY stock under the Base Case scenario is hidden INR. Compared to the current market price of 1 311.5 INR, Dr Reddy's Laboratories Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DRREDDY Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

DRREDDY Competitors Multiples
Dr Reddy's Laboratories Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
1.1T INR 3.1 19.6 12.5 16.3
US
Eli Lilly and Co
NYSE:LLY
946.1B USD 14.5 45.8 30.9 33
US
Johnson & Johnson
NYSE:JNJ
586.8B USD 6.2 21.9 15.2 18.7
CH
Roche Holding AG
SIX:ROG
267.4B CHF 4.3 20.8 12.2 13.8
UK
AstraZeneca PLC
LSE:AZN
226.4B GBP 5.2 29.7 16.4 23.2
CH
Novartis AG
SIX:NOVN
234.9B CHF 5.4 21.6 13.4 17.2
US
Merck & Co Inc
NYSE:MRK
289.8B USD 4.5 15.9 9.9 12
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.6 10.8 8 9.3
US
Pfizer Inc
NYSE:PFE
154.4B USD 2.5 19.9 7.7 10.2
US
Bristol-Myers Squibb Co
NYSE:BMY
121B USD 2.5 17.2 7.2 8.9
P/E Multiple
Earnings Growth PEG
IN
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Average P/E: 22.3
19.6
-1%
N/A
US
Eli Lilly and Co
NYSE:LLY
45.8
32%
1.4
US
Johnson & Johnson
NYSE:JNJ
21.9
7%
3.1
CH
Roche Holding AG
SIX:ROG
20.8
14%
1.5
UK
AstraZeneca PLC
LSE:AZN
29.7
26%
1.1
CH
Novartis AG
SIX:NOVN
21.6
14%
1.5
US
Merck & Co Inc
NYSE:MRK
15.9
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
US
Pfizer Inc
NYSE:PFE
19.9
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
17.2
16%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Average EV/EBITDA: 43.5
12.5
1%
12.5
US
Eli Lilly and Co
NYSE:LLY
30.9
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
15.2
2%
7.6
CH
Roche Holding AG
SIX:ROG
12.2
6%
2
UK
AstraZeneca PLC
LSE:AZN
16.4
13%
1.3
CH
Novartis AG
SIX:NOVN
13.4
5%
2.7
US
Merck & Co Inc
NYSE:MRK
9.9
3%
3.3
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8
1%
8
US
Pfizer Inc
NYSE:PFE
7.7
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.2
-10%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett